Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause
of several cancers, including cervical cancer, and genital warts. Although cervical cancer …

Infrequent provider recommendations continue to be a key barrier to human papillomavirus
(HPV) vaccination, including among adolescents at higher risk for future HPV cancers. To …

Background The human papillomavirus (HPV) vaccine is an underutilized cancer control
practice in the United States. Although individual contextual factors are known to impact …

Purpose: To examine correlates of HPV vaccination uptake in a nationally representative
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …

To assess how the COVID-19 pandemic affected catch-up HPV vaccination among age-
eligible adults (ages 18–45). The current study leverages a national, cross-sectional sample …

Background Despite the high risks associated with human papillomavirus (HPV), the HPV
vaccination rate of men is far lower than women. Most previous review studies have focused …

Abstract Background Parents in the Arab population of Israel are known to be “pro-
vaccination” and vaccinate their children at higher rates than the Jewish population …

The human papillomavirus (HPV) causes many anogenital and oral cancers affecting young
adults in the United States. Vaccination during adolescence can prevent HPV‐associated …

Background: Kidney transplant (KT) recipients have higher incidence of malignancies,
including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have …

Background: Several studies have reported differential vaccine uptake outcomes that are
associated with sociodemographic and socioeconomic characteristics, as well as provider …